Written and maintained by CASRAI Editorial Board
Last updated
Cold chain shipping is the transport of temperature-sensitive products — vaccines, biologics, reagents, blood products, investigational drugs, and some diagnostic specimens — inside a validated, continuously monitored temperature range from the point of dispatch to the point of receipt. For a lab manager, procurement officer, or research administrator, choosing how to ship (or who to ship with) is a compliance decision as much as a logistics one: a broken cold chain can invalidate a reagent lot, void a clinical shipment, or trigger a reportable deviation, so the evaluation criteria below matter more than any single carrier’s marketing claims.
This guide covers what to evaluate when selecting a cold chain shipping approach or provider — packaging systems, monitoring, carrier type, documentation, and the standards that define “compliant” — not a ranked list of vendors. No commercial cold chain provider is endorsed here as “best”; the right choice depends on product type, lane, volume, and your organization’s own validated procedures.
What distinguishes cold chain shipping from ordinary shipping
Ordinary parcel shipping optimizes for speed and cost with no product-temperature obligation. Cold chain shipping adds three requirements that ordinary shipping does not have to meet:
- A validated temperature range that must be held continuously, not just at pickup and delivery — typically frozen (below -15°C or, for some biologics, below -60°C to -80°C), refrigerated/2-8°C, or controlled room temperature (15-25°C), depending on the product’s labeled stability data.
- Continuous monitoring and documentation — a data logger or real-time sensor record that proves the range was held for the entire transit, not just an assumption based on packaging spec.
- A defined excursion response — what happens, and who is notified, if the temperature record shows the range was breached. See CASRAI’s guide to temperature excursions for how receiving sites should evaluate and document a breach once product arrives.
This guide focuses on the shipping/carrier-selection decision. If you’re specifically shipping biological reagents and need packaging and temperature-range specifics, see CASRAI’s cold-chain shipping requirements for biological reagents. If your shipment is a pharmaceutical or investigational product operating under a formal Good Distribution Practice framework, see pharma cold chain logistics and CASRAI’s Good Distribution Practice (GDP) guide for the regulatory layer this article does not duplicate.
Passive vs. active cold chain shipping systems
Every cold chain shipment relies on one of two packaging approaches, and the choice affects both cost and the level of vendor evaluation required:
- Passive systems use insulated packaging (EPS foam, vacuum-insulated panels, or phase-change material panels) plus refrigerant — gel packs, dry ice, or eutectic plates — with no powered components. They are validated to hold a range for a fixed duration (commonly 24, 48, or 96 hours) under defined ambient conditions and are the standard choice for most lab and clinical-trial shipments.
- Active systems use powered refrigeration or heating units built into the shipping container (e.g., roll containers or air-cargo ULDs with mechanical or electric temperature control) and can hold a range indefinitely, independent of ambient conditions or transit duration. They cost substantially more and are typically reserved for high-value biologics, long-haul international lanes, or shipments where transit time is unpredictable.
Whichever system a provider proposes, ask for its qualification data: packaging should be validated against a real or simulated distribution profile (temperature cycling, vibration, altitude/pressure for air transport) rather than a single static chamber test. ISTA’s 7-series procedures (7D for small parcel, 7E for temperature-controlled distribution environments) and ASTM D4169 are the packaging-validation standards most commonly referenced in supplier qualification documentation; USP General Chapter <1079> (Good Storage and Distribution Practices) and <1083> (Good Distribution Practices — Supply Chain Integrity) describe the broader supply-chain-integrity expectations a pharma-grade cold chain provider should be able to demonstrate.
What to evaluate when choosing a cold chain shipping provider
A structured evaluation should cover the following dimensions, in roughly the order they affect risk:
1. Packaging qualification evidence
Request the provider’s actual qualification report for the packaging configuration you’ll use — not a marketing spec sheet. It should state the validated hold time, the ambient temperature range it was tested against, and the test method (ISTA 7-series, ASTM D4169, or an internal protocol referencing those standards).
2. Monitoring and data-logger capability
Confirm whether monitoring is a single-use paper/digital logger read only on arrival, or a real-time GPS/cellular logger that provides in-transit visibility and alerts before a breach becomes irreversible. Real-time visibility costs more but materially shortens the window to intervene (reroute, expedite, or notify the receiving site) if a deviation starts.
3. Regulatory and quality certifications
Depending on what you ship, relevant credentials include GDP compliance (for pharmaceutical and investigational products moving through the EU or under an EU-facing supply chain), IATA’s CEIV Pharma certification (for air-cargo handlers and airlines specializing in time- and temperature-sensitive pharma freight), and, for the shipper’s own facility, ISO 9001 quality-management certification. None of these substitutes for your own qualification of the specific lane and packaging — treat them as a starting filter, not a final answer.
4. Chain-of-custody and documentation
The provider should produce, per shipment: a temperature record covering full transit, a signed chain-of-custody log at each handoff, and packing/shipping documentation that matches what your own SOPs or protocol require for receipt verification. For clinical trial shipments this ties directly into IMP accountability records; see CASRAI’s clinical trial packaging guide for how kit design and blinding requirements interact with cold chain documentation.
5. Network coverage and lane experience
A provider’s general capability matters less than its demonstrated experience on your specific lane — international customs handling, last-mile delivery in the destination region, and realistic transit-time reliability (not best-case transit time) all vary significantly by lane, particularly for cross-border and remote-destination shipments.
6. Excursion response and liability terms
Ask specifically what happens when a shipment shows a temperature excursion: does the provider notify you proactively, what is the claims/liability process for product loss, and is there a documented corrective-action process you can cite in your own quality records.
Standard couriers vs. specialty cold chain carriers
Two broad categories of provider exist, and the right one depends on shipment type and volume, not brand preference:
- General parcel/freight carriers with a cold chain division (major integrated carriers offering temperature-controlled service tiers) provide broad network coverage, predictable pricing, and integration with existing shipping accounts — a reasonable fit for routine, lower-risk shipments such as many reagent and diagnostic-specimen shipments.
- Specialty cold chain / pharma logistics providers focus specifically on temperature-controlled and regulated freight, typically hold GDP and/or CEIV Pharma credentials, and offer active packaging, white-glove handling, and dedicated account management — generally the better fit for high-value biologics, investigational products, or shipments with strict regulatory accountability requirements.
Medical courier services — same-day, chain-of-custody-driven local/regional transport, often used for STAT specimens and time-critical deliveries — are a related but distinct category; see CASRAI’s medical courier services guide if that is the shipment type you’re evaluating.
What a “cold chain shipping solution” actually includes
Searches for cold chain shipping solutions typically mean the full bundled offering, not just the carrier leg. A complete solution generally combines:
- Qualified packaging (passive or active, matched to product and lane)
- A monitoring/data-logger platform, often with a cloud dashboard for in-transit visibility
- Carrier or courier execution (general or specialty, per the comparison above)
- Documentation and chain-of-custody records generated automatically per shipment
- An excursion-management workflow — automated alerting plus a defined response procedure
Some organizations assemble this from separate vendors (a packaging supplier, a monitoring platform, and a carrier); others buy it as a single managed service from a specialty cold chain logistics provider. Which is more cost-effective depends on shipment volume — high-volume shippers often gain more control and lower per-shipment cost by qualifying their own packaging and monitoring and using a carrier purely for transport; low-volume or occasional shippers usually do better with a bundled managed solution.
Cold chain shipping vs. cold chain logistics
The two terms overlap but aren’t identical. Cold chain shipping refers to a single transport leg or shipment — the packaging, carrier, and monitoring for one dispatch. Cold chain logistics is the broader discipline: the end-to-end system of storage, handling, transport, and documentation across an entire supply chain, including warehousing, inventory management, and the GDP-style quality framework that governs it. If you’re evaluating your organization’s overall cold chain program rather than a single shipping decision, CASRAI’s pharma cold chain logistics guide covers the temperature-band and GDP framework in more depth; this guide is scoped to the shipping/carrier-selection decision specifically.
A procurement checklist
Before signing with a cold chain shipping provider, confirm you have documented answers to each of the following:
- What temperature range and hold-time duration is the packaging validated for, and against what test method?
- Is monitoring real-time or read-on-arrival, and what’s the alert/notification process for an in-transit excursion?
- What certifications does the provider hold (GDP, CEIV Pharma, ISO 9001) and are they current?
- What documentation is delivered per shipment, and does it satisfy your own SOP or protocol requirements for receipt verification?
- What is the provider’s track record and stated reliability on your specific lane, not just its network map?
- What is the excursion/claims process, and is it defined in the service agreement rather than handled ad hoc?
- Does the provider integrate with (or replace) your existing inventory and receiving workflows?
Frequently asked questions
What is cold chain shipping?
Cold chain shipping is the transport of temperature-sensitive products within a validated temperature range, using qualified packaging and continuous monitoring, from dispatch to receipt. It applies to vaccines, biologics, reagents, blood products, investigational drugs, and some diagnostic specimens.
What are cold chain shipping solutions?
A cold chain shipping solution is the bundled combination of qualified packaging, temperature monitoring, carrier execution, and documentation needed to ship a temperature-sensitive product compliantly. Solutions can be assembled from separate vendors or purchased as a single managed service from a specialty cold chain logistics provider.
How is cold chain shipping different from cold chain logistics?
Cold chain shipping is a single transport leg or shipment; cold chain logistics is the broader end-to-end system — storage, handling, transport, and documentation across an entire supply chain. A shipping decision is one component of a larger logistics program.
Do I need a specialty cold chain carrier, or will a general carrier’s temperature-controlled service work?
It depends on the product and risk tolerance. Routine, lower-risk shipments (many reagents, diagnostic specimens) are often adequately served by a general carrier’s temperature-controlled tier. High-value biologics, investigational products, or shipments with strict regulatory accountability generally warrant a specialty provider with GDP and/or CEIV Pharma credentials and active-packaging options.
What standards govern cold chain packaging validation?
ISTA’s 7-series test procedures (7D, 7E) and ASTM D4169 are the packaging-validation standards most commonly cited in supplier qualification documentation. USP General Chapters <1079> and <1083> describe broader good storage and distribution practice and supply-chain-integrity expectations for pharmaceutical-grade cold chain.
